欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/2008/001
药品名称Doxorubicine Agila
活性成分
    • doxorubicin hydrochloride 2.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Agila Specialties UK Limited
参考成员国 - 产品名称Netherlands (NL)
Doxorubicine HCL Agila 2 mg/ml concentraat voor oplossing voor infusie
互认成员国 - 产品名称
    • Luxembourg (LU)
      Doxorubicine Agila 2 mg / 1 mL Solution à diluer pour perfusion
    • United Kingdom (Northern Ireland) (XI)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Finland (FI)
    • Poland (PL)
    • Hungary (HU)
    • Cyprus (CY)
      DOXORUBICIN CON FOR SOL FOR INF
许可日期2014/09/04
最近更新日期2017/03/16
药物ATC编码
    • L01DB01 doxorubicin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase